Stiplastics opens a new factory in Saint-Marcellin, France

With this new site, the business will be able to serve the needs of its customers better, especially in terms of connected health

Stiplastics opens a new factory in Saint-Marcellin

Stiplastics is a specialist designer, developer and producer of plastic solutions for the pharmaceutical, healthcare and e-health sectors.

A total of €8.6 million has been invested in this site, enabling the company to pool all its operations and meet its customers' various requirements, especially in terms of the increasing demand for connected health.

The 10,000 m2 site in Saint-Marcellin in the French department of Isère includes the company's administrative headquarters, design office and production workshops (injection, assembly, storage) where manufacturing is based on lean management principles.

The site includes:

  • A dedicated injection workshop with 23 electric injection moulding machines weighing 30 to 300 T
  • An automated assembly area (camera inspections, robot stations) and storage area
  • A test centre with a dedicated injection moulding machine

In response to the rise of e-health, Stiplastics has also set up a new electronics workshop equipped with special tools including test benches. This 150 m2 space is protected from ESD (Electro Static Discharge) by a controlled environment essential for handling electronic components.

The increasing prominence of connected care has also prompted the company to set up IoC [Internet of Care]. This unit is dedicated to designing, developing and producing e-health medical devices, with the main aim of significantly improving treatment and patient comfort.

Stiplastics is therefore now able to design and manufacture medical devices, add electronic components, test them and then pack them ready-to-use for delivery.

”In 2013, we drew up a development plan forecasting almost doubled sales in 5 years. This investment will enable us to meet our targets since we are still on track for turnover of €23 million by the end of 2018,” said Jérôme Empereur, CEO of Stiplastics.

Companies